12/18/2024
4:00 PM | AbbVie (Issuer)
Buckbee Kevin K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:34 PM | AbbVie (Subject)
Buckbee Kevin K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
3:15 PM | AbbVie (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/04/2024
3:16 PM | AbbVie (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/04/2024
1:19 PM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
6:43 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:07 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/02/2024
4:00 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
RAPP EDWARD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:06 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
2:30 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:40 PM | AbbVie (Subject)
Hudson Thomas J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:22 PM | AbbVie (Subject)
Hudson Thomas J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
2:00 PM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
9:54 AM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
6:41 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
3:40 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:17 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
1:07 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
4:00 PM | AbbVie (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/03/2024
10:28 AM | AbbVie (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
| Form 25-NSE | |
05/17/2024
8:03 AM | AbbVie (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
| Form 25-NSE | |
05/07/2024
7:16 PM | AbbVie (Issuer)
Davis Jennifer L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
WADDELL FREDERICK H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
TILTON GLENN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
BURNSIDE WILLIAM H.L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
Roberts Rebecca B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
MEYER MELODY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
Hart Brett J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
AUSTIN ROXANNE S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
RAPP EDWARD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:31 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
10:04 AM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
6:43 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
4:00 PM | AbbVie (Issuer)
RAPP EDWARD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:00 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:00 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad) Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%.
Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with … Find out details on these three critical Nvidia partners immediately. |
03/26/2024
1:31 PM | AbbVie (Subject)
Chevedden John (Filed by)
| Form PX14A6G | |
03/22/2024
4:00 PM | AbbVie (Issuer)
Donoghoe Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
1:29 PM | AbbVie (Subject)
Donoghoe Nicholas (Reporting)
| Form 144/A | |
03/20/2024
6:30 PM | AbbVie (Subject)
Donoghoe Nicholas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:00 PM | AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
3:27 PM | AbbVie (Filer)
| Form ARS | |
03/05/2024
4:30 PM | AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:53 PM | AbbVie (Subject)
Reents Scott T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:50 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Donoghoe Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Thakkar Roopal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Hudson Thomas J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Siatis Perry C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Michael Robert A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Buckbee Kevin K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Reents Scott T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:20 PM | AbbVie (Subject)
RICHMOND TIMOTHY J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
5:06 PM | AbbVie (Subject)
Buckbee Kevin K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:33 PM | AbbVie (Subject)
Michael Robert A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:00 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:52 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
5:12 AM | AbbVie (Filer)
| Form 424B5 | |
02/23/2024
4:00 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
8:14 PM | AbbVie (Subject)
| Form FWP | |
02/21/2024
5:00 PM | AbbVie (Subject)
SALEKI-GERHARDT AZITA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
7:39 AM | AbbVie (Filer)
| Form 424B5 | |
02/20/2024
4:23 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
11:45 AM | AbbVie (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2024
8:00 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:49 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2024
4:00 PM | AbbVie (Issuer)
Siatis Perry C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:50 PM | AbbVie (Subject)
Siatis Perry C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
6:51 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
3:59 PM | AbbVie (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/03/2024
4:17 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:08 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:00 PM | AbbVie (Issuer)
Donoghoe Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
4:02 PM | AbbVie (Subject)
Donoghoe Nicholas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free ABBV Stock Alerts